Literature DB >> 16949403

Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia.

Bas B van Rijn1, Lette B Hoeks, Michiel L Bots, Arie Franx, Hein W Bruinse.   

Abstract

OBJECTIVE: The aim of this study was to report outcome of subsequent pregnancy after early-onset preeclampsia in first pregnancy, and to evaluate potential risk factors for recurrence of preeclampsia and preterm delivery. STUDY
DESIGN: Reproductive follow-up data were obtained for women with a history of early-onset preeclampsia, resulting in delivery before 34 weeks of gestation at the University Medical Center Utrecht, The Netherlands, between July 1993 and September 2002. The relative contributions of demographic data, outcome variables of first pregnancy, and common thrombophilias to the recurrence risk of preeclampsia and preterm delivery in subsequent pregnancy, were estimated by Cox proportional hazard models.
RESULTS: Subsequent pregnancy outcome data were available for 120 women. Overall, preeclampsia reoccurred in the second pregnancy in 30 women (25%). However, 6 women delivered before 34 weeks of gestation (5%), 20 women between 34 and 37 weeks of gestation (17%), and 94 women after 37 weeks of gestation (78%). Forty-one women (34%) had an uneventful pregnancy. Recurrence rates for preeclampsia or preterm delivery were not related to severity of first pregnancy complications, including delivery before 28 weeks of gestation, occurrence of hemolysis, elevated liver enzymes, and low platelet count syndrome, small-for-gestational age infants, and to hereditary or acquired thrombophilias. Chronic hypertension was related to a higher recurrence risk of preeclampsia in the second pregnancy (hazard ratio 2.1, 95% CI 1.0-4.4), and smoking was related to a higher recurrence risk of preterm birth (hazard ratio 2.4, 95% CI 1.1-5.6).
CONCLUSION: Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia is generally favorable.

Entities:  

Mesh:

Year:  2006        PMID: 16949403     DOI: 10.1016/j.ajog.2006.06.044

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

1.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

2.  Effect of Pregnancy Interval on Second Pregnancy Blood Pressure Following Prior Preeclampsia.

Authors:  Lindsay Howe; Erica Hammer; Gary Badger; Ira M Bernstein
Journal:  Reprod Sci       Date:  2017-08-22       Impact factor: 3.060

3.  Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins.

Authors:  Amy K L Chui; Tilini N Gunatillake; Vera Ignjatovic; Paul T Monagle; Padma Murthi; Shaun P Brennecke; John M Whitelock; Joanne M Said
Journal:  Blood Adv       Date:  2017-07-03

Review 4.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

5.  Association of early-onset pre-eclampsia in first pregnancy with normotensive second pregnancy outcomes: a population-based study.

Authors:  J J Chang; L J Muglia; G A Macones
Journal:  BJOG       Date:  2010-05-25       Impact factor: 6.531

6.  Pregnancy induces persistent changes in vascular compliance in primiparous women.

Authors:  Erin A Morris; Sarah A Hale; Gary J Badger; Ronald R Magness; Ira M Bernstein
Journal:  Am J Obstet Gynecol       Date:  2015-01-07       Impact factor: 8.661

7.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

8.  10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study.

Authors:  Wietske Hermes; Arie Franx; Maria G van Pampus; Kitty W Bloemenkamp; Joris A van der Post; Martina Porath; Gabrielle Ponjee; Jouke T Tamsma; Ben W Mol; Christianne J de Groot
Journal:  BMC Pregnancy Childbirth       Date:  2010-06-01       Impact factor: 3.007

Review 9.  The management of hypertension in pregnancy.

Authors:  Andrea G Kattah; Vesna D Garovic
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

Review 10.  Epidemiology of ischemic placental disease: a focus on preterm gestations.

Authors:  Samantha E Parker; Martha M Werler
Journal:  Semin Perinatol       Date:  2014-04       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.